Survival benefit of living-donor liver transplantation in patients with a Model for End-stage Liver Disease over 30 in a region with severe organ shortage

Not Applicable

Completed

• Conditions: Diseases of the digestive system

• Registration Number: KCT0008462
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-05-01
• Last Update Posted: 30 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

Adult
Between September 2005 and December 2021, patients with a MELD score >=30 who were on the waiting list for LT at Severance Hospital were retrospectively reviewed.

Exclusion Criteria

hepatocellular carcinoma (HCC) with distant metastasis
any other malignancy diagnosed within 5 years
significant deterioration in health status within 2 days of placement on the waitlist

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
survival rate

Secondary Outcome Measures

Name	Time	Method
duration of post-transplantation hospital stay, rate of re-transplantation, presence of complications, and occurrence of rejection